Young biotech venture firm raises $500 million for its second fund
Dimension Capital has raised $500 million for its second fund.
Related Articles
Apply now for the Morris Fishbein Fellowship in Medical Editing
Application Deadline: January 4, 2021. The Morris Fishbein Fellowship in Medical Editing is a unique one-year fellowship opportunity offered by JAMA to introduce physicians to…
Ponsegromab for the Treatment of Cancer Cachexia | NEJM
Cachexia is a common complication of cancer and is associated with an increased risk of death. The level of growth differentiation factor 15 (GDF-15), a…
Firefighters in R.I. called to help camel stand up
The camel weighs about 2,000 pounds, according to its owner.
Porch Pirates Are Now Raising the Price You Pay at Checkout – Slashdot
Lost deliveries, shipping delays and theft on the front porch have become such growing problems that companies are making consumers pay for package protection. From…
Alzheimer’s disease mortality among taxi and ambulance drivers: population based cross sectional study
Objective To analyze mortality attributed to Alzheimer’s disease among taxi drivers and ambulance drivers, occupations that demand frequent spatial and navigational processing, compared with other…
Flying Was Already the Worst. Then America Stopped Using Headphones. – Slashdot
Airports are facing a growing nuisance as travelers increasingly watch videos and take calls on speakerphone without headphones, creating tension among passengers at gates and…
Could Medical Marijuana Be Bad for Heart Patients?
THURSDAY, Jan. 11, 2024 (HealthDay News) — Medical marijuana might help ease chronic pain, but it also slightly increases a patient’s risk of a dangerous…
Hour by petrifying hour, how the Boxing Day tsunami unfolded
On this day 20 years ago, an undersea earthquake struck off the coast of Indonesia. Measuring 9.1 in magnitude, the violent tremor was the third…
The Chase for Novel Oral GLP-1 Obesity Meds Adds a New Contender – MedCity News
Corxel Pharmaceuticals has acquired an oral small molecule GLP-1 agonist with potential applications in obesity and diabetes. The Phase 2-ready pill could compete with oral…
Cough That Won’t Quit? Options for OTC Cough Meds and Other Relief
There’s no shortage of products out there that promise to relieve your cough quickly. But what’s the difference between all those pills and syrups? And…
